Back to list

HIV Aging Study

University of North Carolina at Chapel Hill


Description

The purpose of this research study is to enable the Goonetilleke Laboratory at UNC to study disorders or dysfunction in immune cells that can occur with aging. Research study participation involves a single blood collection from persons who are negative for HIV infection or from persons who have been diagnosed with HIV infection.


Keywords:

HIV/AIDS, Men's Health, Women's Health


Category:

Procedures

Qualifications

 


Age
18 - 99 years


Gender
Any


Study Population

Males and females who are > 18 years in overall good health and are HIV positive or HIV negative


Investigator

Michelle Floris-Moore
Director ID Fellowship Training Program, Clinical Associate Professor
Medicine-Infectious Diseases

For questions, contact:

Hannah Thaxton
search4thecure@med.unc.edu

Visit Website

Recruitment Period End

December 31, 2019

Location

Primary Location
CTRC

Study Qualifications

Gender Any

Age Range 18 - 99 years

Participant qualification(s) Cohort A (HIV Negative) 1. HIV negative and willing to be tested to verify negative status. 2. Males and females who are at least 18 years of age. 3. Some schedule flexibility to be able to come to up to 2 research appointments. 4. Willing to be tested to verify negative status for the following diseases: hepatitis B and C, syphilis, gonorrhea, and chlamydia. 5. Overall good health. Cohort B (HIV Positive) 1. HIV Infection and willing to be tested to confirm status, if necessary. 2. Male and females who are at least 18 years of age. 3. Some schedule flexibility to be able to come to up to 2 research appointments. 4. Undetectable viral load for at least 24 months or 2 years. 5. On a stable HIV treatment regimen for a minimum of 24 months. 6. Willing to be tested to verify negative status for the following diseases: hepatitis B and C, syphilis, gonorrhea, and chlamydia.

Not eligible if: • Must be willing to read, understand, and sign research study informed consent • Treated for HCV (Hepatitis C) within the past 6 months. • History of cancer or in treatment for cancer. • Immune deficiency illnesses, other than HIV infection

Number of Visits

    » up to 2 visits In person visit(s)

    1 screening visit and an additional visit to collect the research blood sample if the research blood sample is not collected at screening visit

    » 0 Remote visit(s)

Participation Period

4 weeks

Compensation

Participants will receive the following compensation for participation in this research study: 1. Participants will receive $50.00 when they screen for this research study. 2. Participants will receive $100.00 at the 2nd research study visit when they donate blood samples. If participants complete both the screening visit and enrollment (second) visit on the same day, then they will receive $150. If participants travel greater than 50 miles one way to the visit, we will provide them with compensation for their travel in addition to the visit reimbursement provided above.

By clicking I am interested, your contact information will be sent to the researcher/study coordinator for this study. The coordinator will respond by email with additional information on how to proceed.